Optimal time for the addition of non-corticosteroid immunosuppressants in myasthenia gravis: a single-center retrospective study in China
We found multifactorial clinical factors were highly associated with the add-on of non-steroid immunosuppressants after steroid treatment in patients with MG. Achieving MSE within 6 months, BMI, QMG bulbar muscle score at baseline before steroid treatment, disease duration, and disease relapse may represent crucial influencing factors, which should be considered to improve the long-term prognosis for patients with MG in future studies and practice.
Authors
- Fangfang Yi (ORCID: https://orcid.org/0000-0003-0021-823X)
- Zunbo Li
- Huahua Zhong (ORCID: https://orcid.org/0000-0002-7852-3982)
- Chongbo Zhao (ORCID: https://orcid.org/0000-0001-9481-1418)
- Jianying Xi (ORCID: https://orcid.org/0000-0003-1028-3801)
- Sushan Luo (ORCID: https://orcid.org/0000-0002-9033-7568)
- Dan Chen (ORCID: https://orcid.org/0000-0002-5668-0290)
- Jie Song (ORCID: https://orcid.org/0000-0002-3267-8348)
- Jiaojiao Ma (ORCID: https://orcid.org/0000-0001-9731-3529)
- Zongtai Wu (ORCID: https://orcid.org/0000-0002-8609-1016)
Institutions
- Xuzhou Medical College (CN)
- University of Cambridge (GB)
- Fudan University (CN)
- Xuzhou No.1 People's Hospital (CN)
- Huashan Hospital (CN)
- Loudi Central Hospital (CN)
- Xi'an Chest Hospital (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2024-11-06
- DOI
- https://doi.org/10.3389/fneur.2024.1474508
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Key Research and Development Program of China